Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

gallium Ga 68-labeled tilmanocept

A radioconjugate composed of tilmanocept, a macromolecule consisting of multiple units of mannose and the chelating agent diethylenetriaminepentaacetic acid (DTPA) each covalently attached to a 10 kDa dextran backbone, labeled with the radioisotope gallium Ga 68, with potential use as a tracer for cancer sentinel lymph node (SLN) upon positron emission tomography (PET)/computed tomography (CT). Upon administration, the mannose moiety of gallium Ga 68-labeled tilmanocept selectively binds to macrophage mannose receptor 1 (mannose receptor; MR; CD206) expressed on the surface of macrophages and dendritic cells (DCs) in lymphatic tissue. Upon PET/CT imaging, SLN may be imaged and mapped. Tilmanocept exhibits rapid clearance from the injection site, rapid uptake and high retention within the first draining lymph node, and low uptake by the remaining lymph nodes. CD206, a member of the C-type lectin (CLEC) family that binds mannose or fucose carbohydrate residues, such as those found on the surfaces of many pathogens, is expressed on the surface of macrophages and DCs in lymphatic tissue.
Synonym:68Ga-tilmanocept
gallium Ga 68-labeled diethylenetriamine pentaacetic acid-mannosyl-dextran
gallium Ga 68-labeled DTPA-mannosyl-dextran
gallium-68-tilmanocept
Search NCI's Drug Dictionary